LivaNova Corp (LIVN): Koefisien rega marang pendapatan

Simbol lan logo merek LivaNova plc (LIVN)

LivaNova PLC is currently optimizing its operational processes, focusing on profitable neuromodulation and cardiac surgery systems. The market capitalization-to-revenue ratio reflects the market valuation of this strategy, where the 3.30 mark characterizes this parameter. Growth is supported by alliances with clinics to develop stimulators, as well as joint research with physicians into therapy methods for epilepsy and depression.

LIVN: Rasio rega marang pendapatan LivaNova 04.07.2022 - 13.11.2026

Rincian analitis perusahaan LivaNova Group (LIVN)

- nilai saham lan prakiraan konsensus rega:
Rega saham livanova.com|LIVN - Bagan rega target
- data kapitalisasi bursa:
Kapitalisasi pasar LivaNova Group|LIVN - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- rincian nilai buku perusahaan:
Nilai Akuntansi Saham LivaNova|LIVN - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih livanova.com|LIVN - Total Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal LivaNova PLC|LIVN - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal LivaNova Corp|LIVN - Gunggung utang perusahaan|Utang-utang marang aset resik LivaNova Group|LIVN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan LivaNova|Rasio cepet livanova.com
- informasi bathi lan kelipatan valuasi:
LIVN - Bathi resik perusahaan|Bathi sing dikarepake LivaNova PLC|LIVN - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi LivaNova plc|LIVN - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LivaNova Group|LIVN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajroning taun lumaku LivaNova|LIVN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan livanova.com|LIVN - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep LivaNova PLC
- data total pendapatan lan volume dodolan:
LIVN - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan livanova.com|LIVN - Rasio rega marang pendapatan|Multiplikator forward rega marang pendapatan LivaNova Group
Analisis umum perusahaan:LIVN, livanova.com
Produk seri livanova.com

Steady demand for LivaNova PLC (LIVN) neuromodulation and cardiac surgery systems allows for the assessment of business scaling efficiency through market value. An analysis of the price-to-sales multiple demonstrates the capitalization ratio relative to annual turnover, helping investors determine the premium paid for revenue and correlate the expansion rates of medical technologies with the current share price to identify the asset's fair value.

Perusahaan pesaing

Multiplikator P/S stryker.com (SYK)|Rasio rega marang pendapatan Medtronic MDT|Koefisien rega marang pendapatan Royal Philips (PHG)|SNN: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HOLX (Hologic Medical)|Carlisle Companies (CSL) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan integer.net|AHCO (AdaptHealth) - Multiplikator P/S|Rega marang dodolan SS Innovations International Inc SSII|Multiplikator P/S AVNS|shoulderinnovations.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S VMD (Viemed Healthcare, Inc.)|Koefisien rega marang pendapatan Inogen Inc (INGN)|Owlet Care - Multiplikator P/S|Quipt Home Medical Corp (QIPT) - Kapitalisasi marang pendapatan|POCI: Multiplikator P/S|PAVmed (PAVM) - Multiplikator P/S|Rasio rega marang pendapatan Tivic Health Systems|Rasio rega marang pendapatan MOVE|Kapitalisasi marang pendapatan NUVO (Nuvo Group)